Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
Only registered members have full access to PracticeUpdate content.